Carson Wealth (CWM LLC)’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.3K Buy
5,514
+2,084
+61% +$30.8K ﹤0.01% 3740
2025
Q4
$105K Buy
3,430
+23
+0.7% +$614 ﹤0.01% 3028
2025
Q3
$68K Sell
3,407
-604
-15% -$10.6K ﹤0.01% 3280
2025
Q2
$58K Buy
+4,011
New +$56.8K ﹤0.01% 3163

Other funds holding BBNX

Carson Wealth (CWM LLC)'s BBNX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Beta Bionics (BBNX) stake by 61% in Q1 2026, buying an estimated $30.8K and bringing the position to 5,514 shares worth $55.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3740.

Carson Wealth (CWM LLC) first reported a position in BBNX in Q2 2025 and has held it in 4 quarters since. The position peaked at $105K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 5,514 shares of Beta Bionics worth $55.3K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 2,084 Beta Bionics shares in Q1 2026, an estimated $30.8K.
  • Beta Bionics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3740 holding.
  • Carson Wealth (CWM LLC) first reported a position in Beta Bionics in Q2 2025 and has held it in 4 quarters since.
  • Carson Wealth (CWM LLC)'s Beta Bionics position peaked at $105K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.